Xiaoqian Wang,1 Nenghong Sun,1 Ming Xiao,2 Ziyuan Chen,1 Xiaodan Yang,1 Haijuan Ren,1 Fanceng Ji,1,* Hongyi Xiao1,*1Department of Anesthesiology, Weifang People’s Hospital, Weifang, 261041, People’s Republic of China; 2Department of Pain,
Wang X +7 more
doaj
Background: We hypothesized a class effect of currently available long-acting muscarinic antagonists (LAMAs; i.e. tiotropium as a dry powder inhaler or a soft mist inhaler, aclidinium bromide, and glycopyrronium) in preventing chronic obstructive ...
Yuji Oba, Nazir A. Lone
doaj +1 more source
Thermophysical Properties of Lithium Bromide + 1, 2-Propanediol Aqueous Solutions— Solubility, Density and Viscosity [PDF]
The solubilities, densities and viscosities of lithium bromide (LiBr) + 1, 2-propanediol (HO-CH2-CHOH-CH3) aqueous solution (mass ratio of LiBr/HO-CH2-CHOH-CH3 = 3.5, 4.5 and 5.5) were measured in the mass fraction range from 0.30 to 0.75.
Vineyard, Edward A. +2 more
core +1 more source
Retracted: Clinical Efficacy of Budesonide/Glycopyrronium Bromide/Formoterol in the Treatment of Patients with Acute Respiratory Distress Syndrome and Its Effect on Inflammatory Factors. [PDF]
And Alternative Medicine EC.
europepmc +1 more source
The effect of inhaled extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide on distal and central airway indices, assessed using Functional Respiratory Imaging in COPD (DARWiIN). [PDF]
Skloot GS +8 more
europepmc +1 more source
Pharmacokinetics of extrafine beclometasone dipropionate/formoterol fumarate/glycopyrronium bromide in adolescent and adult patients with asthma. [PDF]
Kuna P +7 more
europepmc +1 more source
Glycopyrronium/Formoterol: A Review in COPD
Compliance with Ethical Standards Funding The preparation of this review was not supported by any external funding. Conflicts of interest Zaina T. Al-Salama and James E.
Zaina T. Al-Salama (7013278) +1 more
core +1 more source
Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
Donald P Tashkin,1 Nicholas J Gross2 1Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA; 2Department of Medicine, University Medical Research LLC, Saint Francis Hospital and Medical Center, Hartford, CT, USA Abstract:
Tashkin DP, Gross NJ
doaj
Real-World Safety and Efficacy of Glycopyrronium Bromide in Japanese Patients with COPD: A 52-Week Post-Marketing Surveillance. [PDF]
Kato C +4 more
europepmc +1 more source
Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma. [PDF]
Chapman KR +7 more
europepmc +1 more source

